J&J, distributors finalize $26B landmark opioid settlement

  • Keith Lewis disposes of used syringes at a needle exchange run by Camden Area Health Education Center in Camden, N.J., Thursday, Feb. 24, 2022. Four companies involved in the opioid industry are finalizing settlements over the addiction crisis in the U.S. in deals that could total $26 billion over 18 years. (AP Photo/Matt Rourke)

CAMDEN, N.J. — Drugmaker Johnson & Johnson and three major distributors finalized nationwide settlements over their role in the opioid addiction crisis Friday, an announcement that clears the way for $26 billion to flow to nearly every state and local government in the U.S.